• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉搭桥手术患者中丙泊酚的肝内和肝外处置情况。

Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery.

作者信息

Lange H, Stephan H, Rieke H, Kellermann M, Sonntag H, Bircher J

机构信息

Department of Clinical Anaesthesiology, University of Göttingen, F.R.G.

出版信息

Br J Anaesth. 1990 May;64(5):563-70. doi: 10.1093/bja/64.5.563.

DOI:10.1093/bja/64.5.563
PMID:2354095
Abstract

In order to clarify the relative contribution of the liver to the short term disposition of propofol, hepatic blood flow was measured during induction of anaesthesia with an i.v. bolus dose of propofol 2 mg kg-1. Total clearance of the drug was 2390 (SD 340) ml min-1, hepatic extraction 82% and hepatic clearance 1060 (260) ml min-1. During the 60-min period of observation, hepatic extraction of propofol increased from 79% to 92%. It is concluded that, within 1 h, only 44% of the administered dose is removed by the liver. Consequently, drug accumulation may occur with repeated dosing or infusion of propofol. The increase in extraction results presumably from slow release of propofol from the soy-bean emulsion.

摘要

为了阐明肝脏对丙泊酚短期处置的相对贡献,在静脉注射2mg/kg丙泊酚诱导麻醉期间测量肝血流量。该药物的总清除率为2390(标准差340)ml/min,肝提取率为82%,肝清除率为1060(260)ml/min。在60分钟的观察期内,丙泊酚的肝提取率从79%增加到92%。结论是,在1小时内,肝脏仅清除44%的给药剂量。因此,重复给药或输注丙泊酚可能会导致药物蓄积。提取率的增加可能是由于丙泊酚从大豆乳剂中缓慢释放所致。

相似文献

1
Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery.冠状动脉搭桥手术患者中丙泊酚的肝内和肝外处置情况。
Br J Anaesth. 1990 May;64(5):563-70. doi: 10.1093/bja/64.5.563.
2
Hepatic disposition of methohexitone in patients undergoing coronary bypass surgery.
Br J Anaesth. 1992 Nov;69(5):478-81. doi: 10.1093/bja/69.5.478.
3
Hepatic disposition of sufentanil in patients undergoing coronary bypass surgery.
Acta Anaesthesiol Scand. 1993 Feb;37(2):154-8. doi: 10.1111/j.1399-6576.1993.tb03692.x.
4
[Hepatic elimination of thiopental in heart surgery patients].
Anaesthesist. 1992 Apr;41(4):171-8.
5
A comparison of the myocardial metabolic and haemodynamic changes produced by propofol-sufentanil and enflurane-sufentanil anaesthesia for patients having coronary artery bypass graft surgery.冠状动脉搭桥手术患者丙泊酚-舒芬太尼与恩氟烷-舒芬太尼麻醉产生的心肌代谢和血流动力学变化比较。
Can J Anaesth. 1991 Nov;38(8):996-1004. doi: 10.1007/BF03008618.
6
Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain.肾脏对丙泊酚在人体中的肝外清除有作用,但肺和脑没有。
Br J Clin Pharmacol. 2005 Aug;60(2):176-82. doi: 10.1111/j.1365-2125.2005.02393.x.
7
Changes in apparent systemic clearance of propofol during transplantation of living related donor liver.
Br J Anaesth. 2005 Nov;95(5):643-7. doi: 10.1093/bja/aei243. Epub 2005 Sep 16.
8
Total i.v. anaesthesia with propofol and alfentanil for coronary artery bypass grafting.丙泊酚和阿芬太尼全静脉麻醉用于冠状动脉旁路移植术
Br J Anaesth. 1991 Jun;66(6):716-8. doi: 10.1093/bja/66.6.716.
9
Hepatic function and indocyanine green clearance during and after prolonged anaesthesia with propofol.丙泊酚长时间麻醉期间及之后的肝功能与吲哚菁绿清除率
Br J Anaesth. 1992 Dec;69(6):643-4. doi: 10.1093/bja/69.6.643.
10
Myocardial metabolism during anaesthesia with propofol--low dose fentanyl for coronary artery bypass surgery.丙泊酚联合低剂量芬太尼用于冠状动脉搭桥手术麻醉期间的心肌代谢
Br J Anaesth. 1991 Apr;66(4):504-8. doi: 10.1093/bja/66.4.504.

引用本文的文献

1
Effects of propofol and sevoflurane on hepatic blood flow: a randomized controlled trial.异丙酚和七氟醚对肝血流的影响:一项随机对照试验。
BMC Anesthesiol. 2020 Sep 22;20(1):241. doi: 10.1186/s12871-020-01150-3.
2
Pharmacology related to paediatric anaesthesia.与小儿麻醉相关的药理学
Indian J Anaesth. 2019 Sep;63(9):698-706. doi: 10.4103/ija.IJA_487_19.
3
In vivo and ex vivo effects of propofol on myocardial performance in rats with obstructive jaundice.异丙酚对梗阻性黄疸大鼠心肌功能的体内和体外作用。
BMC Gastroenterol. 2011 Dec 28;11:144. doi: 10.1186/1471-230X-11-144.
4
Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain.肾脏对丙泊酚在人体中的肝外清除有作用,但肺和脑没有。
Br J Clin Pharmacol. 2005 Aug;60(2):176-82. doi: 10.1111/j.1365-2125.2005.02393.x.
5
[Accuracy of target-controlled infusion (TCI) with 2 different propofol formulations].[两种不同丙泊酚制剂靶控输注(TCI)的准确性]
Anaesthesist. 2004 Oct;53(10):937-43. doi: 10.1007/s00101-004-0753-6.
6
Involvement of human liver cytochrome P4502B6 in the metabolism of propofol.人肝脏细胞色素P4502B6参与丙泊酚的代谢。
Br J Clin Pharmacol. 2001 Mar;51(3):281-5. doi: 10.1046/j.1365-2125.2001.00344.x.
7
Effect of hepatic insufficiency on pharmacokinetics and drug dosing.肝功能不全对药代动力学及给药剂量的影响。
Pharm World Sci. 1998 Oct;20(5):183-92. doi: 10.1023/a:1008656930082.
8
Effect of enteral versus parenteral feeding on hepatic blood flow and steady state propofol pharmacokinetics in ICU patients.肠内营养与肠外营养对ICU患者肝血流及稳态丙泊酚药代动力学的影响。
Intensive Care Med. 1998 Aug;24(8):795-800. doi: 10.1007/s001340050668.
9
Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.镇静剂和镇痛药在治疗躁动危重症患者中的药代动力学和药效学
Clin Pharmacokinet. 1997 Dec;33(6):426-53. doi: 10.2165/00003088-199733060-00003.
10
In vivo assessment of intestinal, hepatic, and pulmonary first pass metabolism of propofol in the rat.大鼠体内异丙酚肠道、肝脏及肺脏首过代谢的评估
Pharm Res. 1996 Jun;13(6):891-5. doi: 10.1023/a:1016057229478.